GC Green Cross Wellbeing Completes Production Facility for Nutritional Injections in Chungbuk

Annual Production Capacity of 62 Million Ampoules and 47 Million Vials of Injectable Products

GC Green Cross Wellbeing Completes Production Facility for Nutritional Injections in Chungbuk Innovation City (Photo by GC Green Cross Wellbeing)

[Asia Economy Reporter Kim Ji-hee] GC Green Cross Wellbeing's new production facility for nutritional injection pharmaceuticals has been completed.

GC Green Cross Wellbeing announced on the 28th that the injection pharmaceutical production facility in Eumseong Innovation City, Chungbuk, has been completed. It took about 18 months since construction began in November 2019.

The facility was built on a site of approximately 34,000㎡ (land area 10,000 pyeong, building area 5,600 pyeong) and is capable of producing 62 million ampoules and 47 million vials of injection products annually. This is three times the existing production capacity. With the steady increase in sales of nutritional injections recently, the company intends to expand the proportion of in-house production to secure production competitiveness.

Inside, there are production lines for ampoules and vials of injections, including the flagship product, the placenta injection ‘Rainec’. Rainec is the only domestic ‘Zahageo hydrolysate’ formulation and holds over 70% market share in the human placenta injection market. In addition, 40 types of nutritional injection pharmaceuticals such as vitamins and minerals are expected to be produced at the new production facility.

A GC Green Cross Wellbeing official explained, "We received building use approval on the 8th and have now entered the pharmaceutical manufacturing approval process for the new production facility," adding, "Full-scale factory operation is planned to begin next year."

Osangsoo, Head of Production at GC Green Cross Wellbeing, said, “The injection pharmaceuticals produced at the new facility will reach customers with the highest quality,” and added, “Based on enhanced production capacity, we will strive to lead the market by securing competitiveness and accelerating new product development.”

This content was produced with the assistance of AI translation services.